[1]李成诚,李 珣,李 明,等.宫颈HPV感染治疗现状[J].医学信息,2018,31(19):40-43.[doi:10.3969/j.issn.1006-1959.2018.19.014]
 LI Cheng-cheng,LI Xun,LI Ming,et al.Current Status of Treatment of Cervical HPV Infection[J].Medical Information,2018,31(19):40-43.[doi:10.3969/j.issn.1006-1959.2018.19.014]
点击复制

宫颈HPV感染治疗现状()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年19期
页码:
40-43
栏目:
综述
出版日期:
2018-10-01

文章信息/Info

Title:
Current Status of Treatment of Cervical HPV Infection
文章编号:
1006-1959(2018)19-0040-04
作者:
李成诚李 珣李 明蒋 洁
湖南医药学院医学院,湖南 怀化 418000
Author(s):
LI Cheng-chengLI XunLI MingJIANG Jie
Medical School,Hunan University of Medicine,Huaihua 418000,Hunan,China
关键词:
宫颈HPV感染治疗
Keywords:
CervicalHPV infectionTreatment
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2018.19.014
文献标志码:
A
摘要:
人乳头瘤病毒感染与宫颈癌及宫颈上皮内瘤样病变的关系密切,高危型人乳头瘤病毒持续感染是引发CIN及子宫颈癌进展和复发的重要病原学因素。本文从药物、物理、手术及综合治疗等方面对宫颈HPV感染的治疗进展进行讨论,为临床治疗提供参考。
Abstract:
Human papillomavirus infection is closely related to cervical cancer and cervical intraepithelial neoplasia.High-risk human papillomavirus infection is an important etiological factor that triggers the progression and recurrence of CIN and cervical cancer.This article discusses the progress of treatment of cervical HPV infection from the aspects of medicine, physics,surgery and comprehensive treatment,and provides reference for clinical treatment.

参考文献/References:

[1]Zhai L,Tumban E.Gardasil-9:A global survey of projected efficacy[J].Antiviral Res,2016(130):101-109. [2]Lee SJ,Yang A,Wu T,et al.Immonotherapy for human papillomavirus-associated disease and cervical cancer:review of clinical and translational research[J].J Gynecol Oncol,2016,27(5):e51. [3]Habiger C,Jager G,Walter M,et al.Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins[J].Journal of virology,2015,90(2):694-704. [4]张树丹,李琪,李戈.重组人干扰素α2b阴道泡腾胶囊治疗HPV感染的Meta分析[J].中国医药导报,2017,31(14):111-115. [5]赵健,杜海军,廖秦平.外用红色诺卡氏菌细胞壁骨架对宫颈癌细胞株-HeLa生长的影响[J].中华实验和临床病毒学杂志,2007,21(1):20-22. [6]魏淑荣,李梅,苏光.纳可佳治疗女性下生殖道人乳头瘤病毒感染的研究[J].北京医学,2011,33(3):254-255. [7]穆庆,史蕾,闫效宇,等.纳可佳治疗宫颈病变伴人乳头瘤病毒感染的疗效观察[J].实用药物与临床,2013,16(2):165-167. [8]梁丽仪,张秀群,杨玮琳,等.探讨壳聚糖宫颈抗菌膜联合聚甲酚磺醛溶液对宫颈HPV感染的治疗效果[J].数理医药学杂志,2016,29(3):324-325. [9]刘宙,黄卫华,肖士滨,等.三氯醋酸联合胸腺五肽治疗宫颈高危型HPV感染的疗效观察[J].当代医学,2016,22(17):118-119. [10]陈旭豪,任汐鹰,江路,等.香港HPV疫苗接种现状以及对我国内地宫颈癌一级预防的借鉴作用[J].现代妇产科进展,2018,27(1):65-67. [11]Moro PL,Zheteyeva Y,Lewis P,et al.Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy:Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System,2006-2013[J].Vaccine,2015,33(4):519-522. [12]Yang A,Farmer E,Wu TC,et al.Perspectives for herapeutic HPV vaccine development[J].J Biomed Sci,2016,23(1):75. [13]张红,付晓丽,蔡翠霞.保妇康栓联合中药治疗宫颈HPV感染临床疗效观察[J].首都医药,2013,4(8):37-38. [14]金芮伊,宗珊,李魏.复方沙棘籽油栓治疗宫颈HPV感染的效果分析[J].中国妇幼保健,2014,29(2):460-461. [15]窦保凤,张金格,刘彬.加味四妙汤对宫颈人乳头瘤病毒感染患者疗效研究[J].辽宁中医杂志,2013,40(6):1141-1142. [16]张蔚苓,胡国华,叶利群.中西医治疗宫颈人乳头瘤病毒感染研究概况[J].山东中医药大学学报,2014,38(2):190-192. [17]叶银利,桑晓庆,熊翡,等.中药联合保妇康栓治疗宫颈高危型HPV感染及CINⅠ的临床观察[J].浙江中医杂志,2015,50(7):478-479. [18]杨君,王彬,刘玉明,等.聚焦超声治疗合并高危型HPV感染的宫颈疾病可行性研究[J].中国超声医学杂志,2013,29(5):446-449. [19]石莹,张秀兴,郭芝亮.冷冻治疗术对宫颈CINⅠ和HPV感染的疗效观察[J].吉林医学,2014,35(33):7331-7333. [20]李媛媛,李雪丽,张晓梅.CO2激光治疗有症状宫颈糜烂合并高危型人乳头瘤病毒感染[J].中华妇幼临床医学杂志(电子版),2017,13(3):332-336. [21]吕翠芬,陈晓辉,田艳,等.不同方法治疗人乳头瘤病毒感染合并宫颈炎的疗效观察[J].中国妇幼保健,2017,32(16):3783-3785. [22]张建华.波姆红外光合并中药治疗慢性宫颈炎合并HPV感染疗效观察[J].中国医药科学,2014,4(4):171-173. [23]刘韵,权效珍,覃小敏.光动力学治疗子宫颈持续性HPV感染临床疗效对比[J].安徽医药,2016,20(1):102-105. [24]李莉,赵霞,张绪婷,等.宫颈环形电切术与冷刀锥切术治疗宫颈上皮内瘤变的Meta分析[J].中国妇幼保健,2017,32(10):2258-2263. [25]谢红,杨菊芳,王莉菲,等.保妇康栓联合聚甲酚磺醛液治疗高危HPV感染的CINⅠ的临床研究[J].山西医科大学学报,2012,43(5):374-376. [26]樊萍,尹遇春,杨艳,等.聚焦超声治疗高危型人乳头状瘤病毒持续感染宫颈炎的临床研究[J].检验医学与临床,2015,12(12):1689-1691. [27]高瑞荣.干扰素联合微波治疗宫颈糜烂合并HPV感染的疗效观察[J].实用妇科内分泌电子杂志,2015,2(6):63-65. [28]朝葵.LEEP术后重组人干扰素α-2b阴道泡腾胶囊治疗宫颈高危型HPV感染的疗效分析[J].中国实用医药,2017,12(12):26-28.

相似文献/References:

[1]杜秋越,刘易欣,陈 凌.免疫组化指标在宫颈微偏腺癌诊断中的应用[J].医学信息,2018,31(09):53.[doi:10.3969/j.issn.1006-1959.2018.09.017]
 DU Qiu-yue,LIU Yi-xin,CHEN Ling.Application of Immunohistochemical Markers in Diagnosis of Minimal Deviationadenocarcinoma of Cervix[J].Medical Information,2018,31(19):53.[doi:10.3969/j.issn.1006-1959.2018.09.017]
[2]董 艳.重组人干扰素α2b阴道泡腾胶囊治疗 宫颈人乳头瘤病毒感染的临床研究[J].医学信息,2018,31(14):147.[doi:10.3969/j.issn.1006-1959.2018.14.045]
 DONG Yan.Clinical Study of Recombinant Human Interferon α2b Vaginal Effervescent Capsule in the Treatment of Human Papillomavirus Infection[J].Medical Information,2018,31(19):147.[doi:10.3969/j.issn.1006-1959.2018.14.045]
[3]唐菁娟.佛山和广州女性宫颈细胞HPV基因分型分析[J].医学信息,2019,32(12):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
 TANG Jing-juan.HPV Genotyping Analysis of Female Cervical Cells in Foshan and Guangzhou[J].Medical Information,2019,32(19):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
[4]叶恬恬,张 婷,曹陈鑫,等.基于文献可视化分析中医药治疗HPV感染的研究热点及趋势[J].医学信息,2024,37(07):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]
 YE Tian-tian,ZHANG Ting,CAO Chen-xin,et al.Research Hotspots and Trends of Traditional Chinese Medicine in the Treatment of HPV Infection Based on Literature Visualization[J].Medical Information,2024,37(19):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]

更新日期/Last Update: 2018-10-29